Myriad Neuroscience (formerly called Assurex Health) is an informatics-based, personalized medicine company providing treatment decision support to healthcare providers for behavioral health and chronic pain conditions. We help people achieve mental wellness with advanced CPGx®, a proprietary combinatorial pharmacogenomics technology providing individualized treatment support for neuropsychiatric conditions. Myriad Neuroscience is the only company in the category with multiple peer-reviewed, published studies that demonstrate the clinical validity and clinical utility of its test, GeneSight®, including its substantial healthcare cost savings benefit. The company has grown every quarter and has expanded internationally through a partnership with Canada’s Centre for Addiction and Mental Health (CAMH).